The Targeted Therapy Global Market Report 2023, provides comprehensive information on the targeted therapy market across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.
Learn More On The Targeted Therapy Market’s Growth:
https://www.thebusinessresearchcompany.com/report/targeted-therapy-global-market-report
The global targeted therapy market size is expected to grow from $97.34 billion in 2022 to $106.79 billion in 2023 at a compound annual growth rate (CAGR) of 9.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global targeted therapy market size is expected to grow to $148.38 billion in 2027 at a CAGR of 8.5%.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=9129&type=smp
New product development are a key trend gaining popularity in the targeted therapy market. Major companies operating in the targeted therapy market are focused on developing new technological solutions to strengthen their position in the market. For instance, in March 2022, Novartis AG, a Switzerland-based multinational pharmaceutical corporation, launched Pluvicto, which was approved by the US Food and Drug Administration (FDA). Pluvicto is the first FDA-approved targeted radioligand therapy (RLT) for eligible patients with mCRPC. It combines a therapeutic radioisotope with a targeted chemical (a radioactive particle). It is a type of targeted cancer therapy in which a therapeutic radioisotope is combined with a targeting chemical. Pluvicto binds to target cells in the circulation, including prostate cancer cells that express the transmembrane protein PSMA. When bonded, the radioisotope’s energy emissions injure the target cells as well as other cells in the region, inhibiting replication and/or leading to cell death.
The targeted therapy market is segmented:
1) By Type: Small Molecule Medicines, Monoclonal Antibodies
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
3) By Application: Breast Cancer, Colorectal Cancer, Leukemia, Lung Cancer, Lymphoma, Renal Cancer, Other Applications
North America was the largest region in the targeted therapy market in 2022.
The table of contents in TBRC’s targeted therapy market report includes:
1. Executive Summary
2. Targeted Therapy Market Characteristics
3. Targeted Therapy Market Trends And Strategies
4. Targeted Therapy Market – Macro Economic Scenario
5. Targeted Therapy Market Size And Growth
.
.
.
26. Africa Targeted Therapy Market
27. Targeted Therapy Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Targeted Therapy Market
29. Targeted Therapy Market Future Outlook and Potential Analysis
30. Appendix
Top Major Players:
- Amgen Inc
- GlaxoSmithKline plc
- Sanofi
- Merck & Co., Inc
- Pfizer Inc
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries. Through the report businesses can gain a thorough understanding of the market’s size, growth rate, major drivers and leading players.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
